Ginkgo Bioworks Holdings, Inc.(DNA)

$10.40—

Chart

Ginkgo Bioworks Holdings, Inc.(DNA)

NYSE

$10.40—

Chart Studio

DNA(DNA)

DNA

Overview Notebook Intelligence Chart History Fundmntls TTM Earnings Analysts News Financials Segments Insiders Institl.DCF Peers

Q3 2026 EPS Estimate

$-0.91

Aug 6, 2026 · Reports after close

Revenue Estimate

$25M

Analyst Sentiment

Wall St. Consensus

Hold

11 analysts·Moderate coverage

Score

5 Buy (45%)2 Hold (18%)4 Sell (37%)

Rating Breakdown

Strong Buy

00%

Buy

545%

Hold

218%

Sell

436%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear

$4.35

-58.2%

Consensus

$7.50

-27.9%

Bull

$12.00

+15.4%

12-Month Target Range11 analysts

$4.35$7.50$12.00

Current $10.40Consensus

Current Price

$10.40

Above Consensus

$2.90

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)

FY2027

Rev+10.18%

EPS—

FY2028

Rev+154.64%

EPS—

FY2029

Rev+24.53%

EPS—

Raw consensus estimates (low / average / high) from covering analysts.

Annual

Metric	FY2026E	FY2027E	FY2028E	FY2029E
Revenue Avg	$106M	$116M	$296M	$369M
Low	$104M	$114M	$291M	$363M
High	$107M	$118M	$301M	$375M
EBITDA Avg	$-106M	$-116M	$-296M	$-369M
Low	$-107M	$-118M	$-301M	$-375M
High	$-104M	$-114M	$-291M	$-363M
EBIT Avg	$-106M	$-116M	$-296M	$-369M
Low	$-107M	$-118M	$-301M	$-375M
High	$-104M	$-114M	$-291M	$-363M
Net Income Avg	$-217M	$-183M	$-176M	$-124M
Low	$-222M	$-187M	$-180M	$-127M
High	$-212M	$-179M	$-173M	$-122M
EPS Avg	$-3.91	$-3.31	$-3.18	$-2.24
Low	$-3.99	$-3.38	$-3.25	$-2.29
High	$-3.83	$-3.23	$-3.11	$-2.19
Analysts (Rev / EPS)	1 / 1	1 / 1	1 / 1	1 / 1

Quarterly

Metric	Q3 2026	Q4 2026	Q1 2027	Q2 2027	Q3 2027	Q4 2027
Revenue Avg	$29M	$32M	$27M	$29M	$29M	$30M
Low	$28M	$31M	$26M	$28M	$28M	$29M
High	$30M	$34M	$28M	$30M	$30M	$31M
EBITDA Avg	$-29M	$-32M	$-27M	$-29M	$-29M	$-30M
Low	$-30M	$-34M	$-28M	$-30M	$-30M	$-31M
High	$-28M	$-31M	$-26M	$-28M	$-28M	$-29M
EBIT Avg	$-29M	$-32M	$-27M	$-29M	$-29M	$-30M
Low	$-30M	$-34M	$-28M	$-30M	$-30M	$-31M
High	$-28M	$-31M	$-26M	$-28M	$-28M	$-29M
Net Income Avg	$-69M	$-75M	$-84M	$-71M	$-65M	$-60M
Low	$-73M	$-79M	$-88M	$-75M	$-68M	$-63M
High	$-66M	$-71M	$-80M	$-67M	$-62M	$-57M
EPS Avg	$-1.16	$-1.26	$-1.41	$-1.19	$-1.09	$-1.00
Low	$-1.22	$-1.32	$-1.48	$-1.25	$-1.15	$-1.05
High	$-1.10	$-1.20	$-1.34	$-1.13	$-1.03	$-0.95
Analysts (Rev / EPS)	1 / 1	1 / 1	1 / 1	1 / 1	1 / 1	1 / 1

Earnings Surprises

Recent Analyst Actions

Aug 25, 2025BTIG

Ginkgo Bioworks price target raised to $9 from $6 at BTIG

Target:$9.00

-25.3%from $12.05

Aug 23, 2024BTIG

Ginkgo Bioworks price target lowered to $7 from $8 at BTIG

Target:$7.00

-15.7%from $8.30

Nov 29, 2022Berenberg Bank

Berenberg Initiates Coverage On Ginkgo Bioworks Holdings with Buy Rating, Announces Price Target of $6

Target:$6.00

+226.1%from $1.84

Aug 16, 2022BTIG

BTIG Maintains Buy on Ginkgo Bioworks Holdings, Raises Price Target to $6

Target:$6.00

+60.4%from $3.74

Jun 16, 2022Jefferies

Jefferies Maintains Buy on Ginkgo Bioworks Holdings, Lowers Price Target to $4.35

Target:$4.35

+68.0%from $2.59

Mar 3, 2022Cowen & Co.

Ginkgo Bioworks, Inc. (DNA) Stock: $12 Price Target And Outperform Rating

Target:$12.00

+210.9%from $3.86

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance